On request of Xvivo Perfusion AB, company registration number 556561-0424, Nasdaq Stockholm AB has admitted the company’s shares to trading on Nasdaq Stockholm, with effect from November 28, 2016. The company’s shares are currently traded on Nasdaq First North Premier.
The company’s share capital consists of 23,614,088[1] shares as per today’s date.
| Short Name: | XVIVO |
| Number of B-shares to be listed: | 23,614,088 |
| ISIN Code: | SE0004840718 |
| Order Book ID: | 90126 |
| Average Daily Turnover: | 109,554 EUR |
| Clearing: | CCP cleared |
| Segment: | Mid cap |
| Market segment: | STO Equities CCP / 182 |
| Tick Size Table: | Other Equities / 227 |
| MIC: | XSTO |
ICB Classification:
| Industry code: | 4000 Health care |
| Supersector code: | 4500 Health care |
For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 60 00, or iss@nasdaq.com.
[1] See prospectus page 77 (Sw. version)